A pharmacovigilance study of anti-depressant agents in psychiatric patients at a tertiary care teaching hospital

D. Phani Bhushan; R. Hari Babu; J. Rashi; M. Tabitha Satya Suvidha; Mounika Susanthi U.; T. Sri Lekha

doi:10.18203/2320-6012.ijrms20201921

Authors

D. Phani Bhushan Department of Psychiatry, NRI Medical College and General Hospital, Guntur, Andhra Pradesh, India
R. Hari Babu Department of Pharmacy Practice, Chebrolu Hanumaiah Institute of Pharmaceutical Sciences, Chowdavaram, Guntur, Andhra Pradesh, India
J. Rashi Department of Pharmacy Practice, Chebrolu Hanumaiah Institute of Pharmaceutical Sciences, Chowdavaram, Guntur, Andhra Pradesh, India
M. Tabitha Satya Suvidha Department of Pharmacy Practice, Chebrolu Hanumaiah Institute of Pharmaceutical Sciences, Chowdavaram, Guntur, Andhra Pradesh, India
Mounika Susanthi U. Department of Pharmacy Practice, Chebrolu Hanumaiah Institute of Pharmaceutical Sciences, Chowdavaram, Guntur, Andhra Pradesh, India
T. Sri Lekha Department of Pharmacy Practice, Chebrolu Hanumaiah Institute of Pharmaceutical Sciences, Chowdavaram, Guntur, Andhra Pradesh, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20201921

Keywords:

Adverse drug reactions, Anti-depressants, Causality assessment scale, Prospective, Weight gain

Abstract

Background: Anti-depressant drugs have great benefit in treating a many psychiatric disorders, including schizophrenia and bipolar disorder, although all these drugs are associated with many potential adverse effects. In this study, the occurrence of adverse effects like weight gain, sleep disturbances, dry mouth were assessed and reported in drug naïve patients Anti-depressant drugs.

Methods: It is a prospective observational study of patients attending Psychiatry department in NRI General Hospital of age 10 to 80 years who were prescribed with anti-depressant drugs. The study was conducted for a period of 8 months from June 2018 to February 2018.

Results: Among 86 patients prescribed with antidepressants, the occurrence of adverse drug reactions due to antidepressants was 60.78% with Selective serotonin reuptake inhibitors being the most common class of drugs implicated for adverse drug reactions followed by 24.49% with Tricyclic antidepressants. A total of 51 adverse drug reactions were noted of which weight gain was most common, closely followed by sleep disturbances and drowsiness. Out of 52 adverse drug reactions assessed for causality, 88.2% of the adverse drug reactions cases were probable, while 11.7% were possible. According to Hartwig and Siegel’s Scale 84.3% of the cases are found to be mild, 15.68% moderate.

Conclusions: The study allows knowing information about the occurrence and pattern of adverse drug reactions associated with Anti-depressant drugs in the population thus reducing its incidence and protecting the user population from available harm.

Metrics

Metrics Loading ...

References

Leape LL, Brennan TA, Laird N, Lawthers AG, Localio AR, Barners BA, et al. The nature of adverse events in hospitalized patients- Results of Harvard medical practice study II. N Engl J Med. 2008; 324:377-84.

CR Jayanthi. Evaluation of pattern, predictibity, severity and preventability of adverse drug reactions. Int J Res Pharmacol Pharmacotherap. 2017;6(2):182-90.

Rieder M, Ferro A. Adverse drug reactions. British J Clini Pharmacol. 2015 Oct;80(4):613-4.

Hadi AM, Neoh CF, Zin RM, Elrggal ME, Cheema E. Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting. Integr Pharm Res Pract. 2017;6:91-8.

Prajapati HK, Joshi ND, Trivedi HR, Parmar MC, Jadav SP, Parmar DM, et al. Adverse drug reaction monitoring in psychiatric outpatient department of a tertiary care hospital. Depression. 2013;63:15-48.

Munoli S, Patil SB. Monitoring of adverse drug reactions to antidepressant drugs in a teaching hospital. Inter J Basic Clini Pharmacol. 2017 Apr;6(4):933-7.

Gor AP, Desai SV. Adverse drug reactions (ADR) in the inpatients of medicine department of a rural tertiary care teaching hospital and influence of pharmacovigilance in reporting ADR. Ind J Pharmacol. 2008 Jan;40(1):37-40.

Lucca JM, Ramesh M, Parthasarathi G, Ram D. A Prospective Surveillance of Pharmacovigilance of Psychotropic Medicines in a Developing Country. Psychopharmacol Bull. 2016 Mar 1;46(1):54.

Mukherjee S, Sen S, Chatterjee SS, Era N, Ghosal M, Tripathi SK. Adverse drug reaction monitoring of antidepressants in the psychiatry out patient department at a tertiary care teaching hospital in India: A cross-sectional observational study. European J Psychol Educational Studies. 2015 Jan 1;2(1):14-9.

Piparva KG, Buch JG, Chandrani KV. Analysis of adverse drug reactions of atypical antipsychotic drugs in psychiatry OPD. Indian J Psychol Med. 2011 Jul;33(2):153-7.

MiShra S, Swain TR, Mohanty M. Adverse drug reaction monitoring of antidepressants in the psychiatry outpatients department of a tertiary care teaching hospital. J Clini Diagnost Res: JCDR. 2013 Jun;7(6):1131.

Lahon K, Shetty HM, Paramel A, Sharma G. A retrospective study of the metabolic adverse effects of antipsychotics, antidepressants, and mood stabilizers in the psychiatry outpatient clinic of a tertiary care hospital in south India. Int J Nutr, Pharmacol, Neurol Dis. 2012 Sep 1;2(3):237.